Alexei Alexeevich Bogdanov

Dr. Alexei Alexeevich Bogdanov


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1999 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
RWRalph Weissleder
Ralph Weissleder
CTChing Tung
Ching Tung
UMUmar Mahmood
Umar Mahmood
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov

1 May 1993 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
TSTueng Shen
Tueng Shen
RWRalph Weissleder
Ralph Weissleder
MPMikhail Papisov
Mikhail Papisov
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov
TBThomas J. Brady
Thomas J. Brady

1 October 1994 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
VTVladimir P. Torchilin
Vladimir P. Torchilin
VOVladimir G. Omelyanenko
Vladimir G. Omelyanenko
MPMikhail Papisov
Mikhail Papisov
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov
VTVladimir S. Trubetskoy
Vladimir S. Trubetskoy
CGChristine A. Gentry
Christine A. Gentry

1 September 1995 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
RWRalph Weissleder
Ralph Weissleder
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov
ENEdward A. Neuwelt
Edward A. Neuwelt
MPMikhail Papisov
Mikhail Papisov

1 February 2000 in Radiology
Verified
Journal Article
Closed access
AMAnna Moore
Anna Moore
EMEdgardo Marecos
Edgardo Marecos
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov
RWRalph Weissleder
Ralph Weissleder
PURPOSE: To investigate the accumulation and cellular uptake of long-circulating dextran-coated iron oxide (LCDIO) particles in malignant neoplasms in vivo. MATERIALS AND METHODS: A gliosarcoma rodent model was established to determine the distribution of a model LCDIO preparation in tumors. LCDIO accumulation in tissue sections was evaluated with multichannel fluorescence microscopy with rhodaminated LCDIO, green fluorescent protein as a tumor marker, and Hoechst 33258 dye as an intravital endothelial stain. Uptake into tumor cells was corroborated with results of immunohistochemical and cell culture uptake experiments. The effect of intratumoral LCDIO uptake on magnetic resonance (MR) imaging signal intensity was evaluated with a 1.5-T superconducting magnet. RESULTS: Tumoral accumulation of LCDIO was 0.11% ± 0.06 of the injected dose per gram of tissue in brain tumors and was sufficient for detection at MR imaging. In tumor sections, LCDIO was preferentially localized in tumor cells (49.0% ± 4.6) but w...

1 January 1997 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
RWRalph Weissleder
Ralph Weissleder
HCHui‐Cheng Cheng
Hui‐Cheng Cheng
ABAnna Bogdanova
Anna Bogdanova
Alexei Alexeevich BogdanovAlexei Alexeevich Bogdanov
Alexei Alexeevich Bogdanov